Literature DB >> 7107384

Cell survival recovery kinetics in the KHT sarcoma following treatment with five alkylating agents and misonidazole.

D W Siemann, R T Mulcahy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107384     DOI: 10.1016/0360-3016(82)90697-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  10 in total

1.  Misonidazole and CCNU chemotherapy for recurrent primary brain tumor.

Authors:  D S Fulton; R C Urtasun; S McKinnon; H Tanasichuk
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

2.  CB 1954 revisited. II. Toxicity and antitumour activity.

Authors:  P Workman; J E Morgan; K Talbot; K A Wright; J Donaldson; P R Twentyman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Potentiation of CCNU activity by misonidazole in metastases.

Authors:  D W Siemann; K L Alliet
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

4.  In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.

Authors:  D W Siemann; K Wolf; S Morrissey; K T Wheeler
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

5.  Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase.

Authors:  M R Horsman; D M Brown; D G Hirst; J M Brown
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

6.  Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.

Authors:  K T Wheeler; C A Wallen; K L Wolf; D W Siemann
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

7.  Effect of the nitroimidazole Ro 03-8799 on the activity of chemotherapeutic agents against a murine tumour in vivo.

Authors:  P W Sheldon; P Gibson
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

8.  Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.

Authors:  R T Mulcahy; N L Dembs; G A Ublacker
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

9.  Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.

Authors:  M R Horsman; J W Evans; J M Brown
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

10.  Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.

Authors:  D Murray; R E Meyn
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.